Please login to the form below

Versartis

This page shows the latest Versartis news and features for those working in and with pharma, biotech and healthcare.

Versartis crashes as VELOCITY trial veers off track

The US biotech's somavaratan proved inferior to Pfzier’s Genotropin. US biotech Versartis saw more than 80% wiped off its share price ahead of the weekend after its growth hormone ... Versartis disappointment has proved a fillip for rival company

Latest news

Pfizer/Opko's long-acting growth hormone misses mark in trial

Also in the running is Versartis, whose somavaratan (VRS-317) is in late-stage trials and was recently licensed to Teijin in Japan.

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

Deal Watch August 2016

252. Versartis. Teijin (JP). Licence Japan. Somavaratan, long-acting form of rhGH, for paediatric and adult growth hormone deficiency in phase II/III in Japan.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Versartis names chief financial officer

Joshua Brumm joins from Pharmacyclics. Versartis has named Joshua Brumm as its first chief financial officer. ... The company's CEO Dr Jeffrey Cleland said: "His appointment comes during a particularly exciting stage of development for Versartis and will

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Account Director, Medical Education: Salary TBC

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Senior Medical Writer: Salary TBC

Account Director – Cheshire based Medical Communications Agency...: D.O.E

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Subscribe to our email news alerts

PMHub

Add my company

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Five key trends in precision and personalised healthcare: Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications: Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word: ...